"Heart Failure, Systolic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Heart failure caused by abnormal myocardial contraction during SYSTOLE leading to defective cardiac emptying.
Descriptor ID |
D054143
|
MeSH Number(s) |
C14.280.434.676
|
Concept/Terms |
Heart Failure, Systolic- Heart Failure, Systolic
- Heart Failures, Systolic
- Systolic Heart Failures
- Systolic Heart Failure
|
Below are MeSH descriptors whose meaning is more general than "Heart Failure, Systolic".
Below are MeSH descriptors whose meaning is more specific than "Heart Failure, Systolic".
This graph shows the total number of publications written about "Heart Failure, Systolic" by people in this website by year, and whether "Heart Failure, Systolic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2015 | 1 | 1 | 2 |
2017 | 9 | 1 | 10 |
2018 | 12 | 0 | 12 |
2019 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Heart Failure, Systolic" by people in Profiles.
-
Duration of Heart Failure and Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure. Circ Heart Fail. 2019 09; 12(9):e006022.
-
Ambulatory Advanced Heart Failure in Women: A Report From the REVIVAL Registry. JACC Heart Fail. 2019 07; 7(7):602-611.
-
Ratio of transmitral early filling velocity to early diastolic strain rate predicts long-term risk of cardiovascular morbidity and mortality in the general population. Eur Heart J. 2019 02 07; 40(6):518-525.
-
Myocardial perfusion during atrial fibrillation in patients with non-ischaemic systolic heart failure: a cross-sectional study using Rubidium-82 positron emission tomography/computed tomography. Eur Heart J Cardiovasc Imaging. 2019 02 01; 20(2):233-240.
-
Is mild asymptomatic left ventricular systolic dysfunction always predictive of adverse events in high-risk populations? Insights from the DAVID-Berg study. Eur J Heart Fail. 2018 11; 20(11):1540-1548.
-
Impact of end stage renal disease on in-hospital outcomes of patients with systolic and diastolic heart failure (insights from the Nationwide Inpatient Sample 2010 to 2014). Int J Cardiol. 2018 Sep 01; 266:174-179.
-
T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF. Clin Res Cardiol. 2019 Feb; 108(2):133-141.
-
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatment. ESC Heart Fail. 2018 10; 5(5):800-808.
-
Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials. J Cardiovasc Pharmacol. 2018 07; 72(1):68-70.
-
Response by Elming et al to Letter Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure". Circulation. 2018 05 15; 137(20):2190.